The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
WINLEVI works differently from any other topical acne treatment
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Commenced operations in flood-affected Himachal Pradesh
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Subscribe To Our Newsletter & Stay Updated
